dual glp 1 gip receptor agonists Major physiological roles of GLP-1 and GIP. Tirzepatide is acting as an... Main physiological actions of the

Berberine is not a GLP-1 agonist, though both compounds influence metabolic pathways

Compare early results with Wegovy and Mounjaro.

Tirzepatide, characterized by its ability to selectively bind and activate receptors for the intestinal hormones GIP and GLP-1, has been tested in numerous clinical studies and is already currently authorized in several countries for the treatment of type 2 diabetes and obesity

DPP-4 inhibition is an interesting line of therapy for treating Type 2 Diabetes Mellitus (T2DM) and is based on promoting the incretin effect

Although, in the last 10 years, the use of GLP-1 RAs, especially semaglutide and liraglutide, has increased, its clinical implications and how it affects metabolic parameters have yet to be fully consolidated